Qilu hospital of Shandong univertisy
Qilu hospital of Shandong univertisy
Jinan, Shandong, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Active, not recruiting | Phase 2 | 2026-05-26 | NCT05585580 | |
| Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not applicable | 2026-05-18 | NCT06157216 | |
| Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not stated | 2026-05-05 | NCT06609759 | |
| A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers | Solid Tumor Cancer; Solid Tumor Malignancies | Recruiting | Phase 2 | 2025-12-04 | NCT07264803 |